In 2026, R&D speed is about learning faster, scaling responsibly and reducing risk in an increasingly complex system, says ...

The initiative is expected to assist the Company in organizing and evaluating a growing body of research data, including formulation records, ingredient studies, and scientific publications related to ...

Lake Mary, Florida / Syndication Cloud / March 12, 2026 / GS Plant Foods Key Takeaways Amino acid fertilizers can ...

Q4 2025 earnings call: nimacimab + semaglutide data, higher-dose expansion, Halozyme SC plans, 2026 catalysts—read now.

The Chinese biotech put the idea to the test in a phase 2 trial of a subcutaneous depot formulation of its GLP-1 receptor agonist ASC30. U.S. investigators randomized 65 people with obesity or who ...

SHINKEI THERAPEUTICS RECEIVES FDA CLEARANCE TO PROCEED WITH PHASE 1 CLINICAL TRIAL FOR MR-101 AND COMPLETES PHASE 2 ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

Source: CUT to develop snakebite treatment medicine – herald Walter Nyamukondiwa-Mashonaland West Bureau Chief ZIMBABWE could ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...